ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer
Clinical trial NCT03485729 · TERMINATED
Trial details
- NCT number
- NCT03485729
- Sponsor
- Jazz Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-21
- Primary completion
- 2023-01-19
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.